22 May 2013
Keywords: idm, commence, phase, ii, trial, uvidem, french
Article | 27 September 2004
French biopharmaceutical concern Immuno-Designed Molecules has gained US Food and Drug Administration clearance to begin a clinical trial of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 September 2004
21 May 2013
© 2013 thepharmaletter.com